Company Profile

Scion Biomededical Inc (AKA:Scion Cardio-Vascular Inc~Scion Capital Corporation)
Profile last edited on: 2/22/2019            CAGE: 4DWB8

Homeostasis pads; vascular control barriers; drug devlivery gels
Year Founded
1996
1st Award Year
2014
Latest Award
2014
Program Status
Inactive
Popularity Index

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

14256 Southwest 119th Avenue
Miami, FL 33186
   (305) 259-8880
   info@scionbiomed.com
   www.scionbiomed.com
Multiple Locations:   
Congressional District:   26
County:   Miami-Dade

Public Profile

Known as Scion Cardio-Vascular until 2013, Scion BioMedical, Inc. is a medical device and biotechnology company that primarily develops and markets anti-microbial barriers as well as drug delivery gells. It's primary product is called Clo-Sur P.A.D. and is a anti-microbial barrier used for rapid control of bleading associated with all vascular access sites. Since 2001, the Clo-Sur has been distributed via an agreement with Medtronic. Scion has also developed other hemostatic products and a hydrogel delivery systems.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
---
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount Project Title
2014 1 NIH $225,000
Intravesical Chitosan Il-12 Therapy in an Orthotopic Mouse Bladder Cancer Model

Key People / Management

  Louis R Rose -- President And Chief Executive Officer

  Wolff Mayer Kirsch

  James Riegler -- Chief Financial Officer

  Louis Rosenwein -- Owner